Open AccessTherapeutic implications of the use of selective beta‐adrenoceptor antagonists in clinical cardiology — A current review
Author(s) -
Comerford M. B.
Publication year - 1978
Publication title -
clinical cardiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.263
H-Index - 72
eISSN - 1932-8737
pISSN - 0160-9289
DOI - 10.1002/clc.4960010302
Subject(s) - medicine , angina , intensive care medicine , beta (programming language) , critical appraisal , cardiology , adrenergic beta antagonists , alternative medicine , propranolol , pathology , myocardial infarction , computer science , programming language
During the last five years of the beta‐blocker era, there has been a slow but steadily increasing interest in the clinical aspects of the selective compounds. A critical appraisal of the works published in the various fields of angina, hypertension, metabolic disorders, respiratory function, stress and exercise responses, suggests a therapeutic progress worthy of the clinician's attention.